0000899243-16-019618.txt : 20160510
0000899243-16-019618.hdr.sgml : 20160510
20160510205433
ACCESSION NUMBER: 0000899243-16-019618
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160506
FILED AS OF DATE: 20160510
DATE AS OF CHANGE: 20160510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Novocure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4YE
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4YE
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WFD Ventures Fund II, L.P.
CENTRAL INDEX KEY: 0001481972
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 161637540
BUSINESS ADDRESS:
STREET 1: C/O WFD VENTURES LLC
STREET 2: 152 WEST 57TH STREET, 10TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212.767.7500
MAIL ADDRESS:
STREET 1: C/O WFD VENTURES LLC
STREET 2: 152 WEST 57TH STREET, 10TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DOYLE WILLIAM F
CENTRAL INDEX KEY: 0001194459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 161637541
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-05-06
0
0001645113
Novocure Ltd
NVCR
0001194459
DOYLE WILLIAM F
C/O NOVOCURE INC.,
20 VALLEY STREAM PKWY SUITE 300
MALVERN
PA
19355
1
0
1
0
0001481972
WFD Ventures Fund II, L.P.
C/O NOVOCURE INC.,
20 VALLEY STREAM PKWY SUITE 300
MALVERN
PA
19355
0
0
1
0
Ordinary Shares
2016-05-06
4
M
0
8349
3.59
A
87080
D
Ordinary Shares
2016-05-06
4
F
0
2381
12.59
D
84699
D
Ordinary Shares
2016-05-06
4
M
0
845091
3.59
A
21619678
I
WFD Ventures Fund II, L.P.
Ordinary Shares
2016-05-06
4
F
0
240976
12.59
D
21378702
I
WFD Ventures Fund II, L.P.
Warrant
3.59
2016-05-06
4
M
0
8349
0.00
D
2016-05-08
Ordinary Shares
8349
0
D
Warrant
3.59
2016-05-06
4
M
0
845091
0.00
D
2016-05-08
Ordinary Shares
845091
0
I
WFD Ventures Fund II, L.P.
Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle possesses sole voting and investment power over shares owned by WFD Ventures Fund II, L.P. (subject to certain rights of the advisory board of WFD Ventures Fund II, L.P. to approve sales of any of the shares owned by WFD Ventures Fund II, L.P.).
Reflects 2,381 shares withheld by the issuer at the market price of $12.59 per share less an exercise price of $3.59 per share to fund the cashless exercise of 8,349 warrants to purchase ordinary shares owned by Mr. Doyle.
Reflects 240,976 shares withheld by the issuer at the market price of $12.59 per share less an exercise price of $3.59 per share to fund the cashless exercise of 845,091 warrants to purchase ordinary shares indirectly owned by Mr. Doyle.
Exercisable at any time through May 8, 2016.
Includes 78,731 shares previously owned by Mr. Doyle.
The transactions reported in the above Table 1 Rows 1 and 2; and Rows 3 and 4 reflect the cashless exercise of warrants. The cashless exercise of the warrants is reported in two lines. The first line of the cashless exercise transaction is coded M in Column 3 of Table 1 and reports in Column 4 the number of shares issuable upon exercise of the warrants had cash been paid to exercise the warrants, together with the exercise price with code A for acquired. The line coded F in Column 3 of Table 1 relates to the same cashless exercise on the preceding line and reports in Column 4 the number of shares deducted from the total number of shares issuable to pay for the cashless exercise of such warrants with code D for disposal. Where the number of shares deducted for the cashless exercise is a fraction, the number has been rounded down to the nearest whole number of shares. The number of shares on a net basis is actually owned by the Reporting Person after the cashless exercise. All transactions are exempt from Section 16(b) by reason of Rule 16b-3. The transactions reported in Table II above reflect the disposition of the same warrants whose cashless exercise is disclosed in Table I above. The number of derivative securities owned after the transactions reported in Column 9 of Table II above includes only warrants with the same exercise price and expiration date.
This Form 4 is filed for William F. Doyle and WFD Ventures Fund II, L.P.
By: /s/ Todd Longsworth, Attorney in fact for William F. Doyle
2016-05-10
By: /s/ Todd Longsworth, Attorney in fact for WFD Ventures Fund II, L.P.
2016-05-10